Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 471-480 of 521 for center for individualized medicine

Edit search filters
  1. Image-based Mapping of Brain Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. Evaluation of Autonomic Function in Individuals With Cornelia de Lange Syndrome (CdLS)

    Rochester, MN

  3. Establishment of a Biorepository of Baseline and Follow-up Saliva Samples Collected from Newly Diagnosed, Treatment-naïve Cancer Patients

    Jacksonville, FL

  4. Genetic Variants in Medication-Induced Torsade de Pointes

    Rochester, MN

  5. Hearing Genomics

    Rochester, MN

  6. A Study to Analyze the Microbiome and Immunology of the Lower and Upper Female Reproductive Tract in Women with Endometriosis

    Rochester, MN

  7. A Natural History Observation and Registry Study of Macular Telangiectasia Type

    Scottsdale/Phoenix, AZ

  8. Testing the Biochemical Behavior of the Fecal Microbiome

    Rochester, MN

  9. A Study of Deep Phenotyping in Patients With ALS

    Rochester, MN

  10. A Study to Analyze Isolation, Activation and Expansion of Mutation Reactive T-cells

    Rochester, MN

.

Mayo Clinic Footer